Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Myeloid leukemia-derived galectin-1 downregulates CAR expression to hinder cytotoxicity of CAR T cells

Fig. 1

Surface CAR expression is more dramatically down-regulated when exposed to U937 myeloid leukemia cells A–C, Surface CD33, CLL-1, and CD123 CAR expression and cytotoxicity of CAR T cells that cocultured with Nalm6CD33 or U937CD33, Nalm6CLL−1 or U937CLL−1 cells, Nalm6CD123 or U937CD123 cells at different effector: target (E: T) ratios. Data shown are mean ± SEM of three experimental replicates. D, Surface CAR expression in NSG mouse model. A–D were representative data from at least three independent experiments with different donors. Assays were performed on day 10 after the initial T-cell culture. Unless otherwise noted, P values are determined by unpaired t-tests. The numbers on the graphs are P values

Back to article page